One68 Global Capital’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-48,066
Closed -$4.66M 83
2019
Q3
$4.66M Sell
48,066
-11,982
-20% -$1.2M 10.64% 3
2019
Q2
$6.15M Buy
60,048
+19,048
+46% +$2.06M 7.74% 4
2019
Q1
$4.67M Buy
+41,000
New +$3.01M 14.01% 2

One68 Global Capital's ONCE Position: Q4 2019 in Review

One68 Global Capital sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 48,066 shares — an estimated $4.66M sold.

One68 Global Capital first reported a position in ONCE in Q1 2019 and held it in 3 quarters. The position peaked at $6.15M in Q2 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • One68 Global Capital reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • One68 Global Capital sold 48,066 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $4.66M.
  • One68 Global Capital first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
  • One68 Global Capital's Spark Therapeutics, Inc. Common Stock position peaked at $6.15M in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on One68 Global Capital's 13F filing for Q4 2019, filed 14 Feb 2020.